LungCancerRx is a new podcast that features conversations among oncologists and patients. From tackling logistical obstacles to handling existential questions, these discussions aim to provide empowerment, knowledge, and hope across the lung cancer community. Eric K. Singhi, MD, a thoracic oncologist in Houston; Aakash Desai, MD, MPH, an assistant professor at the University of Alabama Birmingham’s O’Neal Cancer Center; and Fawzi Abu Rous, MD, a thoracic medical oncologist at Henry Ford Health in Detroit, cohost each episode. “We wanted to bridge the gap between provider communication and patient communication,” explains Dr. Singhi.
Lung Cancer Rx
Claim This Podcastby Oncology News Central
5.0(3 reviews)
13 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
12
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality12
Social0
YouTube0
Engagement32
Podcast Overview
LungCancerRx is a new podcast that features conversations among oncologists and patients. From tackling logistical obstacles to handling existential questions, these discussions aim to provide empowerment, knowledge, and hope across the lung cancer community. Eric K. Singhi, MD, a thoracic oncologist in Houston; Aakash Desai, MD, MPH, an assistant professor at the University of Alabama Birmingham’s O’Neal Cancer Center; and Fawzi Abu Rous, MD, a thoracic medical oncologist at Henry Ford Health in Detroit, cohost each episode. “We wanted to bridge the gap between provider communication and patient communication,” explains Dr. Singhi.
Language
🇺🇲
Publishing Since
6/12/2025
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
12
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality12
Social0
YouTube0
Engagement32
5
Excellent Areas
1
Good Performance
13
Growth Opportunities
excellent
Episode Length
25 minutes
Performing excellently!
good
Show Notes Quality
3.0/5
Recommendations available
Unlock the full report to see detailed tips
needs improvement
Publishing Consistency
Every 18 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind Lung Cancer Rx
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
June 26, 2026
More Accuracy, Less Speed? ASCO 2026 Data Further Support Targeted Therapy in Early-Stage NSCLC
Data presented at ASCO 2026 further underscore the importance of identifying which patients with early-stage NSCLC are eligible for targeted therapies. Jamie E. Chaft, MD, discusses results from the LIBRETTO, CROWN, and EA5142 trials with LungCancerRx hosts Aakash Desai, MD, MPH, Eric K. Singhi, MD, and Fawzi F. Abu Rous, MD.
June 12, 2026
What Do ASCO 2026 Data on NSCLC Co-mutations Mean for Practice?
Ferdinandos Skoulidis, MD, PhD, discusses data on KRAS- mutated NSCLC from ASCO 2026 with Aakash Desai, MD, MPH, Fawzi F. Abu Rous, MD, and Eric K. Singhi, MD.
May 1, 2026
Neoadjuvant Therapy for Early-Stage Lung Cancer: Where Do Things Stand, and What’s Next?
Given recent advances, where do things stand for neoadjuvant therapy in patients with NSCLC? The panel discusses current considerations and what important questions may soon be answered. Patrick Forde MBBCh, PhD, a thoracic medical oncologist at Johns Hopkins University in Baltimore, Maryland, and professor of immuno-oncology at Trinity College Dublin discusses current multidisciplinary approaches to perioperative care in NSCLC with Eric K. Singhi, MD, a thoracic oncologist in Houston, and Aakash Desai, MD, MPH, an assistant professor at the University of Alabama at Birmingham’s O’Neal Cancer Center.
13 total episodes available
Recent guests on Lung Cancer Rx
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Jill Feldman
Guest
Similar Podcasts
Discover related shows you might enjoy
Lung Cancer Considered
IASLC
Lung Cancer Update
Dr. Neil Love
ASCO Daily News
American Society of Clinical Oncology (ASCO)
Up First
NPR
Lung Cancer Voices
Lung Cancer Canada
The Daily
The New York Times
Oncology Brothers
Oncology Brothers
Good Hang with Amy Poehler
The Ringer
Today, Explained
Vox
The Official Game of Thrones Podcast: House of the Dragon
HBO
SmartLess
Jason Bateman, Sean Hayes, Will Arnett
Dr. Death
Audible
Deep-dive analytics for Lung Cancer Rx
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Lung Cancer Rx?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.